SAN FRANCISCO, Nov. 19, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and...
Hence then, the article about ardent health ardt faces investor scrutiny amid problems estimating collection of accounts receivable disclosure drives stock down 33 hagens berman was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman )
Also on site :
- Vue Cinema Chain Halts Liquidation Threat From Coca-Cola Bottling Giant After Settling Unpaid Bill
- 'Dancing With the Stars' Tour Forced to Reschedule Show Due to Impending Snowstorm
- ‘90s Rocker Announces Book Tour in Support of ‘Refreshingly Pure of Heart’ Memoir